Lighting the way to host-directed immunotherapeutics.
Cell Chem Biol
; 29(7): 1067-1070, 2022 07 21.
Article
em En
| MEDLINE
| ID: mdl-35868235
ABSTRACT
Developing broad-spectrum, host-directed antiviral therapeutics can be adapted to combat emerging viruses. In this issue of Cell Chemical Biology, Maarifi and colleagues implement a Nano luciferase reporter-based protein complementation assay to screen for small molecules and identify Gilteritinib, which enhances interferon induction and antagonizes virus replication.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Antivirais
/
Replicação Viral
Idioma:
En
Ano de publicação:
2022
Tipo de documento:
Article